Join Growin Stock Community!

Teleflex incorporatedTFX.US Overview

US StockHealthcare
(No presentation for TFX)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

TFX AI Insights

TFX Overall Performance

TFX AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

TFX Recent Performance

-0.79%

Teleflex incorporated

0.05%

Avg of Sector

-0.31%

S&P500

TFX PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

TFX Key Information

TFX Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

TFX Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Price of TFX

TFX FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

TFX Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-20.49
PE Ratio (TTM)
-
Forward PE
7.90
PS Ratio (TTM)
1.69
PB Ratio
1.38
Price-to-FCF
22.13
METRIC
VALUE
vs. INDUSTRY
Gross Margin
53.30%
Net Margin
-30.56%
Revenue Growth (YoY)
-2.75%
Profit Growth (YoY)
-7.23%
3-Year Revenue Growth
-9.12%
3-Year Profit Growth
-10.02%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-20.49
PE Ratio (TTM)
-
Forward PE
7.90
PS Ratio (TTM)
1.69
PB Ratio
1.38
Price-to-FCF
22.13
Gross Margin
53.30%
Net Margin
-30.56%
Revenue Growth (YoY)
-2.75%
Profit Growth (YoY)
-7.23%
3-Year Revenue Growth
-9.12%
3-Year Profit Growth
-10.02%

  • When is TFX's latest earnings report released?

    The most recent financial report for Teleflex incorporated (TFX) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating TFX's short-term business performance and financial health. For the latest updates on TFX's earnings releases, visit this page regularly.

  • What is the operating profit of TFX?

    According to the latest financial report, Teleflex incorporated (TFX) reported an Operating Profit of 13.87M with an Operating Margin of 2.44% this period, representing a growth of 105.71% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is TFX's revenue growth?

    In the latest financial report, Teleflex incorporated (TFX) announced revenue of 568.98M, with a Year-Over-Year growth rate of -28.47%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does TFX have?

    As of the end of the reporting period, Teleflex incorporated (TFX) had total debt of 2.73B, with a debt ratio of 0.39. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does TFX have?

    At the end of the period, Teleflex incorporated (TFX) held Total Cash and Cash Equivalents of 378.56M, accounting for 0.05 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does TFX go with three margins increasing?

    In the latest report, Teleflex incorporated (TFX) did not achieve the “three margins increasing” benchmark, with a gross margin of 54%%, operating margin of 2.44%%, and net margin of -125.5%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess TFX's profit trajectory and future growth potential.

  • Is TFX's EPS continuing to grow?

    According to the past four quarterly reports, Teleflex incorporated (TFX)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -16.15. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of TFX?

    Teleflex incorporated (TFX)'s Free Cash Flow (FCF) for the period is 151.56M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 11.08% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.